To Top

Content Filter


Or refine filter:
649 Articles available
Oncology

Quadruple Myeloma Combination Treatment Study Begins

PAO-M08-17-NI-027
FDA

The FDA Reauthorization Act Passes the U.S. Senate

Innovation

An Existing Diabetes Drug Could Help Patients with Parkinson’s Disease

PAO-M08-17-NI-025
FDA

FDA Makes Waves with Generic Approvals

PAO-M08-17-NI-024
Acquisition

Mallinckrodt Acquires InfaCare Pharmaceutical Corporation for $425 Million

PAO-M08-17-NI-023
Drug Development

The Advantage of Having a Drug Development Company Behind Manufacturing

Stephen Worsley, Vice President, Business Development, Peregrine Pharmaceuticals & Avid Bioservices, Inc. 

PTV-M06-17-BIO-010
Oncology

Emphasis on Aggressive Cancer Cells

Richard Godfrey, CEO, BerGenBio ASA

PTV-M06-17-BIO-009
Neuroprosthetics

Study Projects an $18 Billion Neuroprosthetics Market by 2028

PAO-M08-17-NI-022
Partnership

Academic-Industry Partnership Receives Funds to Develop Ebola Vaccine

PAO-M08-17-NI-021
Oncology

Genetic Analysis of Solid Tumors Provides Insight on How They Spread

PAO-M08-17-NI-020
Acquistion

LabCorp Makes Another Acquisition

PAO-M08-17-NI-019
Growth Strategy

Boehringer Ingelheim Achieves Good Growth in the First Half of 2017

PR-M08-17-NI-004
Monoclonal Antibodies

New Entamoeba Histolytica Monoclonal Antibodies

PR-M08-17-NI-001
Serialization

UPM Pharmaceuticals Successfully Serializes Its First Pharmaceutical Product

PR-M08-17-NI-002
Acquisition

Avara Pharmaceutical Services acquires Sterile facility from Pfizer in Italy

PR-M08-17-NI-003
NDA

Kite Submits Investigational New Drug Application for KITE-585

PAO-M08-17-NI-018
Acquistion

Brains On-Line Acquired by Charles River Laboratories for $21 million

PAO-M08-17-NI-017
API

Cambrex Invests in New Highly Potent API Manufacturing Capacity

PAO-M08-17-NI-016
Oncology

Bristol-Myers Squibb Will Acquire IFM Therapeutics’ Innate Immune System Stimulators

PAO-M08-17-NI-015
Biosimilars

Finding the Sweet Spot With Biosimilars and mAbs

Federico Pollano, Director, Polpharma Biologics

PTV-M06-17-BIO-008
Oncology

Inside Out: Targeting Proteins on Cancer Cells

Mahesh Narayanan, President & CEO, PepVax, Inc. 

PTV-M06-17-BIO-007
Innovation

A Culture of Innovation in Southeast England

Sarah Haywood, CEO, MedCity

PTV-M06-17-BIO-007
Clinical Trials

Focusing on Clinical and Research Services

Julia Sardayan, Director of Corporate Development, Smooth Drug Development

PTV-M06-17-BIO-006
Innovation

Benchtop Scale with the BIOne

Mark Arjona, Product Line Manager, Biotechnology, Distek, Inc.

PTV-M06-17-BIO-005
Biologics

A Right First Time Approach

Steve Farmer, Senior Director, Sales & Marketing, WuXi Biologics

PTV-M06-17-BIO-004
Innovation

An Expanded Depth of Field: 3D Microscopes for Biotech

Gary Greenberg, CEO, Edge-3D LLC

PTV-M06-17-BIO-003
Innovation

Selectively Building Muscle with SAR

Robert J Wills Ph.D., Executive Chairman, GTx, Inc.

PTV-M06-17-BIO-002
Microbiome

Personalized Genetic Screening Launches in the UK

PAO-M08-17-NI-014
Collaboration

Collaboration Targets Vaccine Technologies to Wipe out HIV-1 and Hep-B

PAO-M08-17-NI-013
Innovation

Celgene’s First-Ever Oral Leukemia Treatment Gets FDA Nod

PAO-M08-17-NI-012
Clinical Trials

Novel Pneumonia-Fighter Enters Pivotal Trial

PAO-M08-17-NI-011
Acquistion

Aptuit Acquisition Positions Evotec for Growth, Expansion

PAO-M08-17-NI-010
Innovation

CMC and Trellis Agree to Develop mAb Therapies to Treat Viral, Bacterial Infections

PAO-M08-17-NI-010
Innnovation

Harvard Researchers Develop a New Adhesive That Adheres Even to Wet Wounds

PAO-M08-17-NI-009
Facility

WuXi Passes Pre-License Inspection for mAb-Based HIV Treatment Production

PAO-M08-17-NI-008
Capacity Expansion

Boehringer Ingelheim Expands Biologics Manufacturing Capacity in California

PAO-M08-17-NI-007
R&D

Michael J. Fox Foundation and CASIS Partner to Grow Parkinson’s Protein in Space

PAO-M08-17-NI-005
Innovation

Joint Program Explores Devices to Treat Gastrointestinal Disease

PAO-M08-17-NI-004
Manufacturing

Lonza Pharm&Biotech Constructing Manufacturing Complex in Switzerland

PAO-M08-17-NI-003
Acquisition

Horizon Discovery Acquires GE CRISPR Unit for $85 Million

PAO-M08-17-NI-002
Partnership

Merck and AstraZeneca Team Up to Fight Cancer

PAO-M08-17-NI-001
Innovation

Novel Therapy Targets Obesity-Linked Disease

PAO-M07-17-NI-035
Innovation

Potential Alzheimer’s Drug Targets Identified

PAO-M07-17-NI-034
Innovation

New Method for Detecting the Zika Virus Developed

PAO-M07-17-NI-033
Investment

Chinese Genetics Company Completes Successful IPO

PAO-M07-17-NI-032
Drug Delivery

The Chemistry Inside Innovation

Donald Loveday, Ph.D., Customer Applications Director, Pharma and Medical, Celanese

PTV-M06-17-BIO-001
Acquisition

Emergent BioSolutions Expands Its Drug Portfolio Through Two Acquisitions

PAO-M07-17-NI-030
Oncology

Telix and OBI License Abzena Cancer Fighters

PAO-M07-17-NI-029
FDA

Vosevi Hepatitis C Treatment Approved by the FDA

PAO-M07-17-NI-028
Innovation

Can Cells Replace Computers?

PAO-M07-17-NI-027
Vaccine

NIH Awards $318 Million Contract to Develop HIV Vaccine

PAO-M07-17-NI-026
Biosimilar

FDA Recommends Approval of Trastuzumab Biosimilar

PAO-M07-17-NI-025
Acquistion

Protein Sciences Snapped Up By Sanofi

PAO-M07-17-NI-024
FDA

Johnson & Johnson Gets FDA Nod for New Treatment for Plaque Psoriasis

PAO-M07-17-NI-023
Drug Delivery

The Future Of Uniquely Delivered Drugs and ADCs

MCP-M07-17-NI-020
ADC

Pfizer’s MYLOTARG Demonstrates Favorable Profile

PAO-M07-17-NI-022
R&D

Science Exchange Raises $28 million in Series C Funding

PAO-M07-17-NI-021
Innovation

Regenerating Knee Cartilage with Stem Cells

PAO-M07-17-NI-020
FDA

Lilly’s Breast Cancer Treatment Granted Priority Review

PAO-M07-17-NI-019
Bioreactor

Single Use Bioreactor Capacity Reaches 4000L

PAO-M07-17-NI-018
Antibiotics

New Class of Antibiotics Looks Promising

PAO-M07-17-NI-017
Cell and Gene Therapy

Shire Submits IND for Hemophilia A Gene Therapy

PAO-M07-17-NI-016
PD-1 Inhibitor

Celgene Corp. and BeiGene Enter Strategic Collaboration

PAO-M07-17-NI-015
Innovation

New Sickle Cell Treatment Approved

PAO-M07-17-NI-014
Acquisition

Agilent Acquires Cobalt, a Raman Innovator

PAO-M07-17-NI-013
Acquisition

Ambry Genetics Acquired by Konica Minolta

PAO-M07-17-NI-012
Innovation

New Diagnostics Agent Designed to Identify Circulating Tumor Cells

PAO-M07-17-NI-011
FDA Approval

Amgen’s Vectibix Approved for RAS Metastatic Colorectal Cancer

PAO-M07-17-NI-010
FDA

Unjamming the Orphan Drug Backlog

PAO-M07-17-NI-009
Expansion

Patheon Invests $45 Million to Fuel Growth

PAO-M07-17-NI-008
Innovation

Research Collaboration Will Focus on the Development of New CAR T-Cell Treatments

PAO-M07-17-NI-007
Biosimilars

FDA Approves Celltrion/Teva BLA for Rituximab Biosimilar

PAO-M07-17-NI-006
Partnership

New Partnership to Tackle Challenging Infectious Diseases

PAO-M07-17-NI-005
Expansion

Pfizer Breaks New Ground in Missouri

PAO-M07-17-NI-003
FDA

FDA Moves to Improve Patient Access

PAO-M07-17-NI-004
FDA

Breckenridge Wins ANDA for Azacitidine

PAO-M07-17-NI-001
Continuous Manufacturing

EMA Approves Continuous Manufacture of Prezista

PAO-M07-17-NI-002
CDMO

Biopharmaceutical Manufacturing Goes Mainstream

PAP-Q2-17-FA-004
Innovation

New Technology Allows Imaging of Complex Molecular Processes

PAO-M06-17-NI-023
Expansion

New Report Predicts Singapore Pharma Market Worth More Than $1 Billion by 2019

PAO-M06-17-NI-022
Innovation

FDA Approves Two Drugs for the Treatment of ADHD

PAO-M06-17-NI-021
Drug Development

New Partnership Targets Colorectal Cancer with Combination Therapy, Including Avelumab

PAO-M06-17-NI-020
FDA

FDA’s Gottlieb Weighs in on the Drug Quality and Security Act (DQSA)

PAO-M06-17-NI-018
Drug Delivery

Recombinant Flu Vaccine Outperforms Egg-based Alternatives

PAO-M06-17-NI-019
Innovation

Number of New Collaborations Announced by Johnson & Johnson Innovation

PAO-M06-17-NI-014
Acquisition

Upsher-Smith Laboratories’ Generics Business Now Part of Sawai Pharmaceutical

PAO-M06-17-NI-016
Biosimilar

Biosimilar Manufacturers Get Favorable Decision from US Supreme Court

PAO-M06-17-NI-017
Drug Delivery

Harvard University Researchers Develop Ultrasound/Nanoparticle Method for Targeted Delivery of Chemotherapeutics

PAO-M06-17-NI-015
Innovation

The New Wave In Cancer Screening: Liquid Biopsy Testing

APR-M04-17-NI-001
Strategy

Icagen on the Road to BIO: Early-Stage Planning for End-Stage Success

Kenneth F. Wertman Ph.D., Senior Vice President, Icagen. View more about Icagen on the Road to BIO.

PTV-M06-17-CL-012
Drug Delivery

Unither Pharmaceuticals on the Road to BIO: Innovation in Delivery

David Kudla, General Manager for North America, Unither Pharmaceuticals. View more about Unither Pharmaceuticals on the Road to BIO.

PTV-M06-17-CL-002
Drug Discovery

Bio-Rad on the Road to BIO: Accelerating Discovery to Improve Lives

Steven Blakely, Global Director of Marketing, Drug Discovery & Development Business, Bio-Rad. View more about Bio-Rad on the Road to BIO.

 

PTV-M06-17-CL-014
Facility Maintenance

CRB on the Road to BIO: Making Your Facility a Future Facility

Matthew Kennedy, Process Specialist, Senior Associate, CRB. View more about CRB on the Road to BIO.

PTV-M06-17-CL-007
Strategic Pathways

UPM Pharmaceuticals on the Road to BIO: Anticipating What’s Around The Bend

James E. Gregory, President & CEO and Ed Scholtz, Ph.D., Vice President of R&D, UPM Pharmaceuticals. View more about UPM Pharmaceuticals on the Road to BIO.

PTV-M06-17-CL-005
Innovation

Emory University on the Road to BIO: Drug Innovation Ventures At Emory (DRIVE)

Todd Sherer Ph.D., Executive Director, Office of Technology Transfer, Emory University
View more about Emory University on the Road to BIO.

PTV-M06-17-CL-013
Biopharmaceutical

Abzena on the Road to BIO: Fueling Biopharmaceutical Development

Sven Lee, Chief Business Officer, Abzena. View more about Abzena on the Road to BIO.

PTV-M06-17-CL-006
Serialization

Alcami on the Road to BIO: Creating Differentiated Value For Biotechs

Natasha Howard, Site Director, MCC, Alcami. View more about Alcami on the Road to BIO.

PTV-M06-17-CL-009
Innovation

Kristine Senft on the Road to BIO: Driving Growth Through Communication, Transparency & Agility

Kristine K. Senft, Pharmaceutical and Chemical Sales and Marketing Executive.

PTV-M06-17-CL-015
Excipients

Celanese on the Road to BIO: Excipients In Biologics

Dr. Donald Loveday – Customer Applications Director, Pharma and Medical, Celanese. View more about Celanese on the Road to BIO.

PTV-M06-17-CL-010
Modular Design

G-CON on the Road to BIO: Managing Mobility, Flexibility & Risk With Modular Design

Michael Katsis, Director of Business Development and Sidney Backstrom, Executive Director of Business Management, G-CON Manufacturing, Inc. View more about G-CON Manufacturing, Inc. on the Road to BIO. 

PTV-M06-17-CL-011
Capacity Expansion

BioVectra on the Road to BIO: Bridging Microbial Demand with Expanded Capacity

Oliver Technow, President, BioVectra Inc.
View more about BioVectra on the Road to BIO.

PTV-M06-17-CL-004
Innovation

M+W Group on the Road to BIO: Ensuring Your Project’s Success

Peter Cramer, AIA, NCARB, Vice President, Life Science Facility Design, M+W Group
View more about M+W Group on the Road to BIO.

 

PTV-M06-17-CL-001
Biopharmaceutical Industry

Avara on the Road to BIO: Taking Direction From Industry Veterans

Bill Pasek, Executive Vice President & Chief Commercial Officer, Avara Pharmaceutical Services
View more about Avara Pharmaceutical Services on the Road to BIO.

PTV-M06-17-CL-008
Strategic Partner

Envigo on the Road to BIO: Staying the Course with a Credible Partner

Joseph Bedford, Ph.D. Corporate Vice President – Strategic Marketing, Envigo
View more about Envigo on the Road to BIO.

PTV-M06-17-CL-003
Road to BIO

The Road To BIO: Day 12 California

See the end of the road as far as the Road To BIO is concerned, as we pull into the San Diego Convention Center! Hear crew views on how the 12 days has taken its toll.

 

PTV-M06-17-NI-012
Road to BIO

The Road To BIO: Day 11 Arizona /// California

Join us for the penultimate day of our journey, as we do our last interview in Tucson and clearly hallucinate in the scorching heat of the Arizona desert before realizing our dream in California.

 

PTV-M06-17-NI-011
Clinical Trials

Checkmate Pharmaceuticals Receives Series B Funding for CMP-001

PAO-M06-17-NI-013
Biologics

Sanofi Will Increase Investments in Biologics

PAO-M06-17-NI-012
FDA

FDA Fast Track Designation Granted for Pfizer and Eli Lilly’s Innovative Pain Treatment

PAO-M06-17-NI-010
Excipient

Trends In Excipient Demand

PMP-M06-17-NI-001
Innovation

3D Patch Reduces Ischemia in Mouse Models

PAO-M06-17-NI-011
Road to BIO

The Road To BIO: Day 10 Texas /// Arizona

The second to last day of the Road to BIO had us kicking up dust and bidding farewell to one of our road warriors in El Paso. View footage from day 10 of our journey from El Paso to Tucson. 

PTV-M06-17-NI-010
Road to BIO

The Road To BIO: Day 9 Texas

Day 9 of our journey ended better than we could have imagined as we made our way from Houston to Fort Stockton, Texas. View highlights from our journey—and the Divide Volunteer Fire Department’s charity cookout — on the Road to BIO 2017.

PTV-M06-17-NI-009
Road to BIO

The Road To BIO: Day 8 Texas

Cannonballs in the pool, excipients in biologics and cleanroom PODs in Aggieland. Join us for a lot of learning — and a bit of fun — on the Road to BIO day 8.  

PTV-M06-17-NI-008
Road to BIO

The Road To BIO: Day 7 Mississippi /// Texas

Join us on day 7 of our journey as we cruise through Mississippi, Louisiana and across the Texas border, stopping along the way to discover a bit about our nation’s history at the Vicksburg National Military Park.

PTV-M06-17-NI-007
Expansion

Takeda Begins Expansion of its Manufacturing Footprint in Ireland

PAO-M06-17-NI-009
Collaboration

Tackling Breast Cancer With a New Type of Collaboration

PAO-M06-17-NI-010
Innovation

Eli Lilly, KeyBioscience Agree to Work on the Development of New Diabetes Drugs

PAO-M06-17-NI-011
Innovation

US Diabetes Patients Now Have Access to an “Artificial Pancreas” for Automatic Insulin Delivery

PAO-M06-17-NI-012
Road to BIO

The Road To BIO: Day 6 Georgia /// Mississippi

Day 6 of the Road to BIO took us from Atlanta, Georgia to Jackson, Mississippi, with plenty of bio and BBQ in between. Hop in!

PTV-M06-17-NI-006
Road to BIO

The Road To BIO: Day 5 South Carolina /// Georgia

Join the Road to BIO through Charleston, South Carolina, a city that lives up to its reputation as one of America’s most hospitable, and one we discovered is steeped in more than just southern charm. 

PTV-M06-17-NI-005
Drug Delivery

Vetter and Microdermics Will Develop Microneedle Delivery Systems

PAO-M06-17-NI-008
Pharma

Boston and San Francisco are the Top Biotech Clusters

PAO-M06-17-NI-007
FDA

Roche CMV Viral Load Test Platform Gets FDA Nod

PAO-M06-17-NI-005
CRO

CRO’s Move to Fill the Gap

PAO-M06-17-NI-006
Road to BIO

The Road To BIO: Day 4 Tennessee /// South Carolina

View footage from day 4 of the Road to BIO, which found us powering through Bristol Tennessee’s Thunder Valley, indulging in some much needed comfort food, and chatting with others about their roads to success.

 

PTV-M06-17-NI-004
Road to BIO

The Road To BIO: Day 3 Pennsylvania /// Tennessee

After our third fuel stop and first service stop, we are back on the Road to BIO 2017. View the highlights from day 3 of our journey through DC, Virginia and Tennessee.

 

PTV-M06-17-NI-003
Innovation

The Road To BIO: Day 2 New York /// Pennsylvania

Tight turns, silly questions, and lots of learning on the Road to BIO. View footage from day 2 of our 12-day journey to BIO 2017. 

 

PTV-M06-17-NI-002
Road To BIO

The Road To BIO: Day 1 Massachusetts /// New York

Take a ride with us. View the footage from week one of our journey through the Northeast.

 

PTV-M06-17-NI-001
Acquisition

AMRI Signs Acquisition Agreement

PAO-M06-17-NI-005
Biosimilar

Pfizer Gets FDA Advisory Committee Nod for Biosimilar

PAO-M06-17-NI-002
Continuous Manufacturing

Cardio Candidate to be Manufactured Continuously

PAO-M06-17-NI-003
Innovation

Merck Signs Global License Agreement for Potential Treatment for Alzheimer’s Disease

PAO-M06-17-NI-001
Innovation

New Data May Lead to the Development of Drugs to Prevent Heart Problems in Diabetics

PAO-M06-17-NI-004
Innovation

Mayo Clinic and Baxter Launch Patient Centric Kidney Disease Initiative

PAO-M06-17-NI-004
Biologics

Pharma Revs Up Cancer-Fighting CAR T-Cell Therapy

MCP-M06-17-NI-001
Innovation

Behind the RFP: Project Optimization and Technology Integration

Daniel Lachapelle, CEO Global Business Unit Life Sciences & Chemicals (LSC), M+W Group

 

PTV-M03-17-IN-018
Biologics

The Road to Biologics’ Continued Success

PAP-Q2-17-EN-001
Biologics

Biologics: Driving Force in Pharma

PAP-Q2-17-NO-001
Process Analytical Technology

Making Real-Time Process Analytical Technology In Biomanufacturing A Reality

PAP-Q2-17-IL-001
Drug Discovery

Disease-In-A-Dish: Leveraging in vitro Human Models to Advance Drug Discovery

PAP-Q2-17-CL-006
Quality by Design

Speeding Development And Reducing Costs With Analytical Quality By Design

PAP-Q2-17-CL-006
Regulatory

Implications of Serialization for the U.S. Pharma Industry

PAP-Q2-17-CL-001
Regulation

Serialization: The First Steps In Sales Unit Traceability and Data Management

PAP-Q2-17-CL-002
CDMO

Supporting the Tech Transfer Continuum for Cell & Gene Therapies

PAP-Q2-17-CL-003
Biologics

Propagating a Full Spectrum of Services for ADC Development and Manufacture

PAP-Q2-17-CL-007
Regulatory

Moving Quality to the Forefront Brings Measurable Results

PAP-Q2-17-CL-008
Biologics

Making Strides: Biologics Push Forward

PAP-Q2-17-FA-001
Clinical Trials

Clinical Trials Find a Device for Growth

PAP-Q2-17-FA-002
Drug Delivery

The Search for Alternative Delivery Methods Continues

PAP-Q2-17-FA-003
Innovation

From Blobs to Hearts: Understanding the 3D Bioprinting Revolution

PAP-Q2-17-TT-001
API

Optimizing API Production as a True Manufacturing Partner

PAP-Q2-17-CL-009
API

Small Molecule Injectable Manufacturing: Challenges and Complexities

PAP-Q2-17-CL-013
CDMO

Building a One-Stop Shop CDMO for Biopharmaceuticals

PAP-Q2-17-CL-012
Drug Delivery

The People’s Choice: Premeasured Single Dosage Forms

PAP-Q2-17-CL-014
Equipment

Design of Complex Biopharmaceutical Facilities: Considering Options and Alternatives

PAP-Q2-17-CL-011
Innovation

Designing Flexibility for Added Value

PAP-Q2-17-CL-015
Equipment

Fit Biopharmaceutical Facilities: A Predictive Maintenance Approach

PAP-Q2-17-CL-010
Oral Solid Dosage

Nice Symposium Oral Solid Dose 2017: Bringing the Supply Chain Together to Tackle Development Challenges

PAP-Q2-17-NS-001
Biologic

Q: If You Could Have One Piece of Biologic Manufacturing Equipment Improved, What Would It Be and Why?

PAP-Q2-17-RT-001
Roundtable

Q: How is Growth in the Biosimilars Market Impacting the Development of New Biologics Manufacturing Equipment Technologies?

PAP-Q2-17-RT-003
Roundtable

Q: What is the Most Significant Recent Advancement in Downstream Bioprocessing Technology? Why is it so Important?

PAP-Q2-17-RT-002
Innovation

Flow Chemistry: Pathway for Continuous API Manufacturing

SCM-M05-NI-023
Clinical Trials

HIV Vaccine Demonstrates “Remarkable” Rates

PAO-M05-17-NI-039
Acquisition

Bioverativ to Acquire True North

PAO-M05-17-NI-038
Innovation

The Link Between Cancer and the Flu Virus

PAO-M05-17-NI-037
Pharma

Top Biotech Companies at Home in Ireland

PAO-M05-17-NI-035
Clinical Trials

Priority Review Given to Kite’s Axicabtagene Ciloleucel

PAO-M05-17-NI-034
Immuno-Oncology‎

Bristol-Meyers Squibb, Array BioPharma Enter Strategic Collaboration

PAO-M05-17-NI-036
CDMO

Boehringer Ingelheim Expands its Contract Manufacturing in China

PAO-M05-17-NI-029
CRISPR

MilliporeSigma Increases the Efficiency of Gene Editing

PAO-M05-17-NI-030
Microbial Fermentation

BioVectra Inc. to Increase Capacity by Forty Percent

PAO-M05-17-NI-032
Data Management

Keeping Track of Antibiotic Resistance Just Got Easier

PAO-M05-17-NI-031
Oncology

Common Biomarker Guides New Cancer Therapy

PAO-M05-17-NI-033
Pain Management

The Cost of Pain

PAO-M05-17-NI-027
Innovation

Pharma’s Back to Nature Trend

PAO-M05-17-NI-028
Acquisition

Astellas Completes Acquisition of Ogeda

PAO-M05-17-NI-026
Clinical Trials

CFDA Calls for Clinical Trial Reform

PAO-M05-17-NI-025
Blockbuster

Johnson & Johnson Looks Forward to Ten Blockbuster Drugs by 2021

PAO-M05-17-NI-023
FDA Approval

Fresh RA Treatment from Sanofi/Regeneron Approved

PAO-M05-17-NI-024
Drug Delivery

Trends in the Topical Delivery of Dermatology Medications

MCM-M05-NI-001
Business

US Spending on Medicines Slows by Half, According to Study

PAO-M05-17-NI-017
CDMO

Orphan Xermelo Begins Commercial Manufacture

PAO-M05-17-NI-018
Innovation

Pfizer Collaborates with Gene Editing Company Sangamo Therapeutics on Hemophilia A Treatment

PAO-M05-17-NI-022
Innovation

Modeling Patient-Specific Kidney Diseases by Combining Engineered Stem Cells and Chip Technology

PAO-M05-17-NI-018
Clinical Trials

New Licensing Agreement Could Lead to Improved Brain Cancer Treatment

PAO-M05-17-NI-017
Acquisition

Patheon Acquired by Thermo Fisher Scientific

PAO-M05-17-NI-016
Pharma

First New ALS Treatment in Decades Approved by FDA

PAO-M05-17-NI-015
Innovation

Inside the Immune System 

PAO-M05-17-NI-014
Clinical Trials

Harmonized Protocol Templates Available for Clinical Trial Sponsors

PAO-M05-17-NI-013
Clinical Trials

AstraZeneca, Pieris Pharmaceuticals Join Forces to Combat Respiratory Diseases

PAO-M05-17-NI-011
Innovation

Pharma’s Great Automation Migration

PMP-M05-17-NI-001
CDMO

Patheon Adds Sterile Fill/Finish Capability to Greenville NC site

PAO-M05-17-NI-013
Innovation

There’s New Hope for Keeping Aging Muscles Healthy

PAO-M05-17-NI-012
Acquisition

Allergan Zeltiq Aesthetics Acquisition Finalized

PAO-M05-17-NI-010
Innovation

Creating A Unique Cleanroom, Faster

Jason Dollarhide, President, Cleanroom Constructors Incorporated

PTV-M01-17-IN-017
Equipment

A Fill Line Is More Than Just a Fill Line: Incorporating What’s Hidden in Facilities

Christa Myers, Senior Pharmaceutical Engineering Specialist, CRB
Melissa Holshouser, Associate, Senior Facility & Process Planner, CRB

PTV-M01-17-IN-015
Engineering

The Move Towards Modularity

George Walker, Executive Director, AES Clean Technology 

PTV-M01-17-IN-014
Continuous Manufacuring

Quantum Leaps in Continuous Processing and Tablet Imprinting

Edward Novit, Business Development Manager, Freund-Vector Corp. 

PTV-M01-17-IN-013
Clinical Trial

Expanding Into Clinical Trials

Jeff Schwegman, CEO, AB Biotechnologies 

PTV-M03-17-IN-012
Innovation

Millipore Sigma Sponsoring LabCentral

PAO-M05-17-NI-002
Acquisition

Fresenius Kabi Expands its Generics and Biosimilars Businesses

PAO-M05-17-NI-006
Pharma

BIO Applauds USTR’s 2017 Special 301 Report on Global Challenges to IP

PAO-M05-17-NI-009
Pharma

Demand for Ovarian Cancer Drugs Forecast to Increase

PAO-M05-17-NI-005
Innovation

Recipharm Delivers First Serialized Drug Products in Saudi Arabia

PAO-M05-17-NI-003
Acquistion

Takeda Acquisition Followed by a Speedy Approval

PAO-M05-17-NI-001
Equipment

Manufacturing Precision Machines

Dennis Martin, Regional Sales Manager, Cozzoli Machine Company 

PTV-M01-17-IN-016
API

Connecting the Dots for Clients

Michael Hughey, Sales Manager, ACIC Machinery

 

PTV-M03-17-IN-009
Equipment

X-Ray and Inspection Solutions for Quality Control

James Chrismas, International Pharmaceutical Business Manager, Loma Systems

PTV-M03-17-IN-007
Equipment

Batch to Continuous: Changing Customer Mindset

Mike Barker, Sales Manager, L.B. Bohle

PTV-M03-17-IN-002
Continuous Manufacturing

Innovation and Formulation

Thomas Hofmaier, Head of Business Unit Process Technology Pharma, Glatt Air Techniques

PTV-M03-17-IN-005
Continuous Manufacturing

Engineering Machines for Solid Dosage Forms and the Global Market

Klaus Groschel, Managing Director Sales & Marketing, Xertecs

PTV-M03-17-IN-010
Continuous Manufacturing

Solving Cleaning Challenges and the Question of Cosmeceuticals

Michael Moussourakis, Director, Alconox, Inc.

PTV-M03-17-IN-011
Continuous Manufacturing

Acoustics for Separation and Filtration of Applications

Stanley Kowalski III, Co-Founder, Chairman & CEO, FloDesign Sonics

PTV-M03-17-IN-008
Packaging

Trends in Pharma, Lyophilization Evolution and Aggressive Molecules

Ian Whitehall, Chief Marketing Officer, SP Industries

PTV-M03-17-IN-006
Regulatory

The Mission of Commissioning Agents, Inc.

RJ Filannino, Manager of Technical Services, Mid-Atlantic, Commisioning Agents Inc. (CAI)

PTV-M03-17-IN-004
Equipment

Better Data in Bioprocessing

Bernd-Ulrich Wilhelm, CEO, bbi-biotech GMbH

PTV-M03-17-IN-003
HPAPI

The Introduction of Robotics: Creating a Truly Sterile Environment

Jason S. Collins, Director, Process Architecture, IPS

 

PTV-M03-17-IN-001
Acquisition

Sawai Pharmaceutical Acquires Upsher‐Smith Generics Business

PAO-M04-17-NI-029
Innovation

Medical Cannabis Continues to Cultivate Innovation

PAO-M04-17-NI-028
Immuno-oncology Therapies

Combinational Immunotherapies: The Bright Future of Cancer Treatment

MCP-M04-17-NI-001
CDMO

Latest Developments in Cellular and Gene Therapies

MCP-M03-17-NI-001
Biologics

Biosimilar Era Begins to Blossom

PAO-M04-17-NI-027
Discovery

First On-Label Abuse-Deterrent Opioid Approved

PAO-M04-17-NI-026
Discovery

TRULANCE Gets Veteran to Pilot IBS Therapy Launch

PAO-M04-17-NI-024
FDA

Novartis CAR-T Cell Therapy Receives Breakthrough Therapy Designation

PAO-M04-17-NI-025
CDMO

Upcoming: Women in Leadership Forum

PAO-M04-17-NI-023
CDMO

Bioprocessing Capacity is in High Demand

PAO-M04-17-NI-022
CDMO

Cobra Biologics Invests in Gene Therapy

PAO-M04-17-NI-020
CDMO

Meeting Customer Needs

James E. Gregory, President and CEO, UPM Pharmaceuticals

PTV-M01-17-NS-014
Excipients

Co-Processed Excipients Help Formulate Better OSDs

PMP-A04-17-NI-001
Clinical Trials

Advancing Clinical Trial Efficiency with Electronic Informed Consent

APR-M03-17-NI-001
API

Anticipating Future Guidelines By Utilizing The Latest Technologies In Particle Characterization

POP-M03-17-NI-001
CDMO

Famar Expands Into North America

PAO-M04-17-NI-019
Discovery

Mestoblast’s Stem-cell Therapy for Heart Failure Reaches Phase III

PAO-M04-17-NI-013
CDMO

Topical Drug Formulations – Strong Growth Based on New Understandings: Q&A with BASF Pharma Solutions

PAO-M04-17-NI-014
CDMO

Rentschler Sharpens its Competitive Edge

PAO-M04-17-NI-017
Acquisition

Bain Capital, Cinven and STADA Make a Deal

PAO-M04-17-NI-016
Discovery

23andMe Personal Genome Service Gets FDA Nod

PAO-M04-17-NI-015
Discovery

Inovio Ebola DNA Vaccine Demonstrates Robust Immune Response

PAO-M04-17-NI-012
Equipment

Idle No Longer: Strategizing Around Used Equipment

Adam Covitt, Vice President, Federal Equipment

PTV-M11-16-AP-031
CRO

What’s New in Bioanalysis?

Chad Briscoe, Executive Director, PRA Health Sciences

PTV-M11-16-AP-019
Excipients

Making it Simple

Ken Seufert, Managing Director, Meggle USA

PTV-M11-16-AP-030
API

MicroJet Reactor (MJR) for APIs

Michelle Hall, Marketing Director, CoreRx

PTV-M11-16-AP-028
Quality

Quality is Everything

Marga Vines, Business Development Manager, Grifols

PTV-M11-16-AP-029
CDMO

Grand River Has Come a Long Way

Tom Ross, President and CEO, Grand River

PTV-M11-16-AP-026
Biologics

Dan Peizer Reveals Catalant’s Newest Acquisition

Dan Peizer, Global Director of Corporate Marketing, Catalent

PTV-M11-16-AP-027
CDMO

Catalent Completes Controlled-Temperature Capacity

PAO-M04-17-NI-012
Manufacturing